191 related articles for article (PubMed ID: 24644051)
1. In vivo effect of mutant ELOVL4 on the expression and function of wild-type ELOVL4.
Mandal NA; Tran JT; Zheng L; Wilkerson JL; Brush RS; McRae J; Agbaga MP; Zhang K; Petrukhin K; Ayyagari R; Anderson RE
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2705-13. PubMed ID: 24644051
[TBL] [Abstract][Full Text] [Related]
2. Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.
Barabas P; Liu A; Xing W; Chen CK; Tong Z; Watt CB; Jones BW; Bernstein PS; Križaj D
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5181-6. PubMed ID: 23479632
[TBL] [Abstract][Full Text] [Related]
3. The Elovl4 Spinocerebellar Ataxia-34 Mutation 736T>G (p.W246G) Impairs Retinal Function in the Absence of Photoreceptor Degeneration.
Agbaga MP; Stiles MA; Brush RS; Sullivan MT; Machalinski A; Jones KL; Anderson RE; Sherry DM
Mol Neurobiol; 2020 Nov; 57(11):4735-4753. PubMed ID: 32780351
[TBL] [Abstract][Full Text] [Related]
4. DHA does not protect ELOVL4 transgenic mice from retinal degeneration.
Li F; Marchette LD; Brush RS; Elliott MH; Le YZ; Henry KA; Anderson AG; Zhao C; Sun X; Zhang K; Anderson RE
Mol Vis; 2009 Jun; 15():1185-93. PubMed ID: 19536303
[TBL] [Abstract][Full Text] [Related]
5. Effect of reduced retinal VLC-PUFA on rod and cone photoreceptors.
Bennett LD; Brush RS; Chan M; Lydic TA; Reese K; Reid GE; Busik JV; Elliott MH; Anderson RE
Invest Ophthalmol Vis Sci; 2014 Apr; 55(5):3150-7. PubMed ID: 24722693
[TBL] [Abstract][Full Text] [Related]
6. Retinal bioavailability and functional effects of a synthetic very-long-chain polyunsaturated fatty acid in mice.
Gorusupudi A; Rallabandi R; Li B; Arunkumar R; Blount JD; Rognon GT; Chang FY; Wade A; Lucas S; Conboy JC; Rainier JD; Bernstein PS
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33526677
[TBL] [Abstract][Full Text] [Related]
7. Current Progress in Deciphering Importance of VLC-PUFA in the Retina.
Bennett LD; Anderson RE
Adv Exp Med Biol; 2016; 854():145-51. PubMed ID: 26427405
[TBL] [Abstract][Full Text] [Related]
8. Elovl4 5-bp-deletion knock-in mice develop progressive photoreceptor degeneration.
Vasireddy V; Jablonski MM; Mandal MN; Raz-Prag D; Wang XF; Nizol L; Iannaccone A; Musch DC; Bush RA; Salem N; Sieving PA; Ayyagari R
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4558-68. PubMed ID: 17003453
[TBL] [Abstract][Full Text] [Related]
9. Examination of VLC-PUFA-deficient photoreceptor terminals.
Bennett LD; Hopiavuori BR; Brush RS; Chan M; Van Hook MJ; Thoreson WB; Anderson RE
Invest Ophthalmol Vis Sci; 2014 Apr; 55(7):4063-72. PubMed ID: 24764063
[TBL] [Abstract][Full Text] [Related]
10. A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report.
Gyening YK; Boris K; Cyril M; Brush RS; Nassogne MC; Agbaga MP
Acta Neuropathol Commun; 2023 Aug; 11(1):131. PubMed ID: 37568198
[TBL] [Abstract][Full Text] [Related]
11. Homozygous Expression of Mutant ELOVL4 Leads to Seizures and Death in a Novel Animal Model of Very Long-Chain Fatty Acid Deficiency.
Hopiavuori BR; Deák F; Wilkerson JL; Brush RS; Rocha-Hopiavuori NA; Hopiavuori AR; Ozan KG; Sullivan MT; Wren JD; Georgescu C; Szweda L; Awasthi V; Towner R; Sherry DM; Anderson RE; Agbaga MP
Mol Neurobiol; 2018 Feb; 55(2):1795-1813. PubMed ID: 29168048
[TBL] [Abstract][Full Text] [Related]
12. ELOVL4 Mutations That Cause Spinocerebellar Ataxia-34 Differentially Alter Very Long Chain Fatty Acid Biosynthesis.
Gyening YK; Chauhan NK; Tytanic M; Ea V; Brush RS; Agbaga MP
J Lipid Res; 2023 Jan; 64(1):100317. PubMed ID: 36464075
[TBL] [Abstract][Full Text] [Related]
13. Very long chain polyunsaturated fatty acids and rod cell structure and function.
Marchette LD; Sherry DM; Brush RS; Chan M; Wen Y; Wang J; Ash JD; Anderson RE; Mandal NA
Adv Exp Med Biol; 2014; 801():637-45. PubMed ID: 24664753
[TBL] [Abstract][Full Text] [Related]
14. Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease.
Raz-Prag D; Ayyagari R; Fariss RN; Mandal MN; Vasireddy V; Majchrzak S; Webber AL; Bush RA; Salem N; Petrukhin K; Sieving PA
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3603-11. PubMed ID: 16877435
[TBL] [Abstract][Full Text] [Related]
15. Elovl4 5-bp deletion knock-in mouse model for Stargardt-like macular degeneration demonstrates accumulation of ELOVL4 and lipofuscin.
Vasireddy V; Jablonski MM; Khan NW; Wang XF; Sahu P; Sparrow JR; Ayyagari R
Exp Eye Res; 2009 Dec; 89(6):905-12. PubMed ID: 19682985
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of very long-chain polyunsaturated fatty acids in hepatocytes expressing ELOVL4.
Agbaga MP; Logan S; Brush RS; Anderson RE
Adv Exp Med Biol; 2014; 801():631-6. PubMed ID: 24664752
[TBL] [Abstract][Full Text] [Related]
17. Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse.
Schori C; Agbaga MP; Brush RS; Ayyagari R; Grimm C; Samardzija M
PLoS One; 2018; 13(1):e0190514. PubMed ID: 29293603
[TBL] [Abstract][Full Text] [Related]
18. ELOVL4 protein preferentially elongates 20:5n3 to very long chain PUFAs over 20:4n6 and 22:6n3.
Yu M; Benham A; Logan S; Brush RS; Mandal MNA; Anderson RE; Agbaga MP
J Lipid Res; 2012 Mar; 53(3):494-504. PubMed ID: 22158834
[TBL] [Abstract][Full Text] [Related]
19. Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4.
McMahon A; Butovich IA; Mata NL; Klein M; Ritter R; Richardson J; Birch DG; Edwards AO; Kedzierski W
Mol Vis; 2007 Feb; 13():258-72. PubMed ID: 17356513
[TBL] [Abstract][Full Text] [Related]
20. Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy.
Logan S; Agbaga MP; Chan MD; Kabir N; Mandal NA; Brush RS; Anderson RE
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5446-51. PubMed ID: 23509295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
